menu
    • menu

    Company profile for Samsung Bioepis

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Samsung Bioepis is a biopharmaceutical company focused on increasing patient access to high-quality medicines through the development of biosimilars.
    Samsung Bioepis is advancing an extensive pipeline of biosimilar candidates through process innovation and an unwavering commitment to quality.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Samsung Bioepiskorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    107, Cheomdan-daero, Yeonsu-gu, Incheon
    Telephone
    Telephone
    +82 - 32 - 455 - 6114
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.samsungbioepis.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/samsung-bioepis
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Samsung Bioepis Launches Denosumab Biosimilars, Obodence & Xbryk
    Samsung Bioepis Launches Denosumab Biosimilars, Obodence & Xbryk

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251130748101/en/Samsung-Bioepis-Announces-Launch-of-Denosumab-Biosimilars-OBODENCE-and-XBRYK-in-Europe

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    Samsung Bioepis Settles Pyzchiva (Ustekinumab) in Europe
    Samsung Bioepis Settles Pyzchiva (Ustekinumab) in Europe

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251105941733/en/Samsung-Bioepis-Reaches-Settlement-Agreement-for-PYZCHIVA-ustekinumab-in-Europe

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    Samsung Bio Spins Off To Enhance Focus As CDMO
    Samsung Bio Spins Off To Enhance Focus As CDMO

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/samsung-biologics-completes-spin-off-to-strengthen-its-focus-as-a-pure-play-cdmo-302602213.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Established Samsung Epis to Drive Growth for Samsung Bioepis
    Established Samsung Epis to Drive Growth for Samsung Bioepis

    02 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030908044/en/Newly-Established-Samsung-Epis-Holdings-to-Drive-Growth-for-Samsung-Bioepis-and-a-New-Subsidiary

    BUSINESSWIRE
    02 Nov 2025
    Share Share
    Samsung Bioepis to Launch Byooviz in Europe in January 2026
    Samsung Bioepis to Launch Byooviz in Europe in January 2026

    29 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251029326593/en/Samsung-Bioepis-to-Commercialize-BYOOVIZ-ranibizumab-in-Europe-from-January-2026

    BUSINESSWIRE
    29 Oct 2025
    Share Share
    Samsung Bioepis Publishes Q4 2025 US Biosimilar Market Report
    Samsung Bioepis Publishes Q4 2025 US Biosimilar Market Report

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251023516661/en/Samsung-Bioepis-Releases-Fourth-Quarter-2025-US-Biosimilar-Market-Report-Providing-Annual-Biosimilar-Trends-and-Future-Market-Trajectory

    BUSINESSWIRE
    23 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search